We are live on ! Find out more
WA

Waverly Advisors Portfolio holdings

AUM $13.4B
1-Year Est. Return 18.56%
This Fund
S&P 500
This Quarter Est. Return
-14.83%
1 Year Est. Return
+18.56%
3 Year Est. Return
+54.07%
5 Year Est. Return
+50.41%
10 Year Est. Return
+168.39%
AUM
$1.09B
AUM Growth
-$89.7M
Cap. Flow
+$98.4M
Cap. Flow %
9.01%
Top 10 Hldgs %
64.74%
Holding
228
New
23
Increased
96
Reduced
58
Closed
22

Sector Composition

Rank Sector Weight
1 Technology 2.5%
2 Financials 2.35%
3 Healthcare 0.9%
4 Industrials 0.74%
5 Consumer Staples 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEE icon
151
NextEra Energy
NEE
$187B
$359K 0.03%
4,638
+22
+0.5% +$1.68K
CVS icon
152
CVS Health
CVS
$137B
$357K 0.03%
3,861
+264
+7% +$25.8K
ABT icon
153
Abbott
ABT
$180B
$351K 0.03%
3,231
-137
-4% -$15.6K
LMT icon
154
Lockheed Martin
LMT
$134B
$347K 0.03%
807
-48
-6% -$21.1K
GE icon
155
GE Aerospace
GE
$367B
$346K 0.03%
8,692
+2,222
+34% +$108K
SBUX icon
156
Starbucks
SBUX
$118B
$345K 0.03%
4,516
-270
-6% -$20.7K
BMY icon
157
Bristol-Myers Squibb
BMY
$127B
$343K 0.03%
4,463
-122
-3% -$9.29K
TSLA icon
158
Tesla
TSLA
$1.24T
$332K 0.03%
1,479
+465
+46% +$127K
GL icon
159
Globe Life
GL
$13.5B
$323K 0.03%
3,314
-22,188
-87% -$2.18M
EMR icon
160
Emerson Electric
EMR
$82.9B
$322K 0.03%
4,052
-66
-2% -$5.82K
IVE icon
161
iShares S&P 500 Value ETF
IVE
$48.9B
$322K 0.03%
+2,341
New +$346K
BCRX icon
162
BioCryst Pharmaceuticals
BCRX
$2.37B
$317K 0.03%
29,929
+50
+0.2% +$516
ELV icon
163
Elevance Health
ELV
$81.9B
$315K 0.03%
654
+6
+0.9% +$2.97K
NSC icon
164
Norfolk Southern
NSC
$78.8B
$305K 0.03%
1,340
META icon
165
Meta Platforms (Facebook)
META
$1.51T
$300K 0.03%
1,855
-277
-13% -$53.4K
SPGI icon
166
S&P Global
SPGI
$126B
$298K 0.03%
887
+2
+0.2% +$713
XLV icon
167
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$295K 0.03%
2,299
ROM icon
168
ProShares Ultra Technology
ROM
$1.13B
$286K 0.03%
10,000
LUV icon
169
Southwest Airlines
LUV
$22.1B
$283K 0.03%
7,827
+74
+1% +$3.18K
AMGN icon
170
Amgen
AMGN
$203B
$281K 0.03%
1,156
+51
+5% +$12.5K
IWO icon
171
iShares Russell 2000 Growth ETF
IWO
$14.5B
$281K 0.03%
+1,364
New +$304K
ENB icon
172
Enbridge
ENB
$124B
$276K 0.03%
6,531
QQQ icon
173
Invesco QQQ Trust
QQQ
$455B
$274K 0.03%
978
+201
+26% +$62.4K
QCOM icon
174
Qualcomm
QCOM
$176B
$273K 0.03%
2,140
+389
+22% +$52.8K
XLF icon
175
State Street Financial Select Sector SPDR ETF
XLF
$55.6B
$272K 0.02%
8,638
-1,173
-12% -$40.5K

Similar funds

Waverly Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Waverly Advisors held 228 positions worth $1.09B, down 7.6% from $1.18B the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Waverly Advisors deployed $98.4M of net new capital in Q2 2022, opening 23 new positions and adding to 96 existing holdings. Its largest new stake was Avantis Emerging Markets Equity ETF: 204,969 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 2.5% of assets, up from 2.4% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares Core MSCI Emerging Markets ETF, an estimated $10.1M trimmed.

  • Waverly Advisors's largest Q2 2022 buy was Avantis Emerging Markets Equity ETF: 204,969 shares worth $10.7M.
  • Waverly Advisors added most to iShares Core S&P 500 ETF in Q2 2022, an estimated $16.5M increase.
  • Waverly Advisors's biggest Q2 2022 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $10.1M.
  • Waverly Advisors fully exited Vanguard Dividend Appreciation ETF in Q2 2022, selling an estimated $487K.
  • Waverly Advisors's ten largest holdings make up 65% of its $1.09B portfolio in Q2 2022.
  • Waverly Advisors opened 23 new positions and closed 22 in Q2 2022.
  • Waverly Advisors's portfolio value fell 7.6% quarter-over-quarter to $1.09B.

Based on Waverly Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.